Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8705)
All Articles published online
|
Publishing Process of This Article
|
Jul 6, 2016 (publication date) through Apr 26, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Nephrology
ISSN
2220-6124
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Ta MHT, Schwensen KG, Liuwantara D, Huso DL, Watnick T, Rangan GK. Constitutive renal Rel/nuclear factor-κB expression in Lewis polycystic kidney disease rats. World J Nephrol 2016; 5(4): 339-357 [PMID: 27458563 DOI: 10.5527/wjn.v5.i4.339] |
|---|---|
| URL: | https://www.wjgnet.com/2220-6124/full/v5/i4/339.htm |
| Number | Citing Articles |
| 1 |
Jelena Kotur-Stevuljević, Jelena Savić, Milena Simić, Jasmina Ivanišević. Redox homeostasis, oxidative stress and antioxidant system in health and disease: The possibility of modulation by antioxidants. Arhiv za farmaciju 2023; 73(4): 251 doi: 10.5937/arhfarm73-45369
|
| 2 |
Jennifer Q.J. Zhang, Sayanthooran Saravanabavan, Ashley N. Chandra, Alexandra Munt, Annette T.Y. Wong, Peter C. Harris, David C.H. Harris, Paul McKenzie, Yiping Wang, Gopala K. Rangan. Up-Regulation of DNA Damage Response Signaling in Autosomal Dominant Polycystic Kidney Disease. The American Journal of Pathology 2021; 191(5): 902 doi: 10.1016/j.ajpath.2021.01.011
|
| 3 |
Jennifer Q. J. Zhang, Sayanthooran Saravanabavan, Gopala K. Rangan. Effect of Reducing Ataxia-Telangiectasia Mutated (ATM) in Experimental Autosomal Dominant Polycystic Kidney Disease. Cells 2021; 10(3): 532 doi: 10.3390/cells10030532
|
| 4 |
Ashley N. Chandra, Sayanthooran Saravanabavan, Gopala K. Rangan. Role of DNA-Dependent Protein Kinase in Mediating Cyst Growth in Autosomal Dominant Polycystic Kidney Disease. International Journal of Molecular Sciences 2021; 22(19): 10512 doi: 10.3390/ijms221910512
|
| 5 |
Priyanka S. Sagar, Jennifer Zhang, Magda Luciuk, Carly Mannix, Annette T. Y. Wong, Gopala K. Rangan, Giovanna Valenti. Increased water intake reduces long-term renal and cardiovascular disease progression in experimental polycystic kidney disease. PLOS ONE 2019; 14(1): e0209186 doi: 10.1371/journal.pone.0209186
|
| 6 |
Michelle H. T. Ta, Kristina G. Schwensen, Sheryl Foster, Mayuresh Korgaonkar, Justyna E. Ozimek-Kulik, Jacqueline K. Phillips, Anthony Peduto, Gopala K. Rangan, David Long. Effects of TORC1 Inhibition during the Early and Established Phases of Polycystic Kidney Disease. PLOS ONE 2016; 11(10): e0164193 doi: 10.1371/journal.pone.0164193
|
| 7 |
Hai Duc Nguyen. Interactions Between Heavy Metal Mixtures and Kidney Function: Gender-Stratified Analyses. Exposure and Health 2023; doi: 10.1007/s12403-023-00594-5
|
| 8 |
Maria Fragiadaki. Lessons from microRNA biology: Top key cellular drivers of Autosomal Dominant Polycystic Kidney Disease. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2022; 1868(5): 166358 doi: 10.1016/j.bbadis.2022.166358
|
| 9 |
Jennifer Qin Jing Zhang, Jane Burgess, Daria Stepanova, Sayanthooran Saravanabavan, Annette T.Y. Wong, Philipp Kaldis, Gopala K. Rangan. Role of cyclin-dependent kinase 2 in the progression of mouse juvenile cystic kidney disease. Laboratory Investigation 2020; 100(5): 696 doi: 10.1038/s41374-019-0360-4
|
| 10 |
Maria V. Irazabal, Vicente E. Torres. Reactive Oxygen Species and Redox Signaling in Chronic Kidney Disease. Cells 2020; 9(6): 1342 doi: 10.3390/cells9061342
|
| 11 |
Tracy Tran, Cheng Jack Song, Trang Nguyen, Shun-Yang Cheng, Jill A. McMahon, Rui Yang, Qiuyu Guo, Balint Der, Nils O. Lindström, Daniel C.-H. Lin, Andrew P. McMahon. A scalable organoid model of human autosomal dominant polycystic kidney disease for disease mechanism and drug discovery. Cell Stem Cell 2022; 29(7): 1083 doi: 10.1016/j.stem.2022.06.005
|
| 12 |
Jennifer Q. J. Zhang, Sayanthooran Saravanabavan, Alexandra Munt, Annette T. Y. Wong, David C. Harris, Peter C. Harris, Yiping Wang, Gopala K. Rangan. The role of DNA damage as a therapeutic target in autosomal dominant polycystic kidney disease. Expert Reviews in Molecular Medicine 2019; 21 doi: 10.1017/erm.2019.6
|
| 13 |
Chiara Formica, Dorien J.M. Peters. Molecular pathways involved in injury-repair and ADPKD progression. Cellular Signalling 2020; 72: 109648 doi: 10.1016/j.cellsig.2020.109648
|